in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Metabolix names new CEO
2:42 PM MST | December 19, 2013 | Rebecca Coons
Polyhydroxyalkanoate (PHA) firm Metabolix (Cambridge, MA) announced today that its Board of Directors has appointed Joseph Shaulson as its new president and CEO, effective 2 January 2014, and as a member of the Board of Directors, effective immediately. Shaulson, previously executive v.p./Arch Chemicals, will succeed Richard Eno, who will remain with the company until 31 January 2014 to assist with the transition. Eno has been president and CEO of Metabolix since March 2008. Shaulson, 48, brings nearly 20 years of experience as a senior executive with...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee